Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1 - PubMed (original) (raw)
Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1
M S McAlister et al. Eur J Biochem. 1998.
Free article
Abstract
CD5 is a type-I transmembrane glycoprotein found on thymocytes, T-cells and a subset of B-cells. The extracellular region consists of three domains belonging to the scavenger receptor cysteine-rich (SRCR) superfamily, for which no three-dimensional structure has been obtained. Recombinant soluble CD5 domain 1 (CD5d1), the N-terminal SRCR domain, has been expressed in both chinese hamster ovary (CHO) cells and Pichia pastoris. CD5d1 was shown to be correctly folded by binding to the CD5 monoclonal antibody Leul. Circular dichroism and NMR analyses indicate that CD5d1 has a high beta-sheet content. CD5d1 from both CHO cells and P. pastoris have very similar properties. The disulphide bonding pattern was determined and is consistent with that found for the group-A SRCR domain of type-1 macrophage scavenger receptor and MARCO, the macrophage receptor with collagenous structure. Observations have been made of the role of glycosylation of CD5. P. pastoris expression provides large quantities of correctly folded recombinant CD5d1 for multidimensional NMR and for X-ray crystallographic studies. The whole extracellular region of CD5, expressed as a chimaera with rat CD4 domains 3 and 4 (cCD5d1-3-CD4d3+4), was studied by electron microscopy and carbohydrate analysis to gain an overview of the structure of the extracellular portion of intact CD5. Carbohydrate analysis identified N-linked glycans on CD5 domains 1 and 2, and sialylated O-linked glycans on the linker peptide between domains 1 and 2. Electron microscopy and carbohydrate analysis together suggest that the extracellular region of CD5 forms a rod-like structure with domain 1 distal from the cell surface and separated from domains 2 and 3 by an O-glycosylated peptide linker region.
Similar articles
- NMR analysis of the N-terminal SRCR domain of human CD5: engineering of a glycoprotein for superior characteristics in NMR experiments.
McAlister MS, Davis B, Pfuhl M, Driscoll PC. McAlister MS, et al. Protein Eng. 1998 Oct;11(10):847-53. doi: 10.1093/protein/11.10.847. Protein Eng. 1998. PMID: 9862202 - Three-dimensional solution structure and conformational plasticity of the N-terminal scavenger receptor cysteine-rich domain of human CD5.
Garza-Garcia A, Esposito D, Rieping W, Harris R, Briggs C, Brown MH, Driscoll PC. Garza-Garcia A, et al. J Mol Biol. 2008 Apr 18;378(1):129-44. doi: 10.1016/j.jmb.2008.02.006. Epub 2008 Feb 12. J Mol Biol. 2008. PMID: 18339402 - The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system.
Sarrias MR, Grønlund J, Padilla O, Madsen J, Holmskov U, Lozano F. Sarrias MR, et al. Crit Rev Immunol. 2004;24(1):1-37. doi: 10.1615/critrevimmunol.v24.i1.10. Crit Rev Immunol. 2004. PMID: 14995912 Review. - CD6-ligand interactions: a paradigm for SRCR domain function?
Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA, Bajorath J. Aruffo A, et al. Immunol Today. 1997 Oct;18(10):498-504. doi: 10.1016/s0167-5699(97)01130-4. Immunol Today. 1997. PMID: 9357143 Review.
Cited by
- A ligand for CD5 is CD5.
Brown MH, Lacey E. Brown MH, et al. J Immunol. 2010 Nov 15;185(10):6068-74. doi: 10.4049/jimmunol.0903823. Epub 2010 Oct 15. J Immunol. 2010. PMID: 20952682 Free PMC article. - Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation.
Penney SJ, Gallant ME, Grant MD. Penney SJ, et al. AIDS Res Ther. 2014 Sep 15;11:30. doi: 10.1186/1742-6405-11-30. eCollection 2014. AIDS Res Ther. 2014. PMID: 25237383 Free PMC article. - 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48.
Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. Brown MH, et al. J Exp Med. 1998 Dec 7;188(11):2083-90. doi: 10.1084/jem.188.11.2083. J Exp Med. 1998. PMID: 9841922 Free PMC article. - Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.
Zu Y, Ren Q, Zhang J, Su H, Lu Q, Song Y, Zhou J. Zu Y, et al. Exp Hematol Oncol. 2024 Oct 26;13(1):104. doi: 10.1186/s40164-024-00577-5. Exp Hematol Oncol. 2024. PMID: 39462383 Free PMC article. - CD5 Deficiency Alters Helper T Cell Metabolic Function and Shifts the Systemic Metabolome.
Whitley KV, Freitas CMT, Moreno C, Haynie C, Bennett J, Hancock JC, Cox TD, Pickett BE, Weber KS. Whitley KV, et al. Biomedicines. 2022 Mar 18;10(3):704. doi: 10.3390/biomedicines10030704. Biomedicines. 2022. PMID: 35327505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous